Skip to main content
. 2018 Jun;18(6):675–683. doi: 10.1016/S1473-3099(18)30073-2

Figure 2.

Figure 2

Prevalence of isoniazid resistance, estimated through genetic sequencing compared with phenotypic testing

Data are the adjusted prevalence of isoniazid resistance from genetic sequencing compared with the true prevalence of isoniazid resistance from phenotypic testing, stratified by rifampicin-resistant and rifampicin-susceptible cases. Absolute numbers are shown in the appendix.